127 related articles for article (PubMed ID: 35644085)
21. Effects of lanreotide Autogel primary therapy on symptoms and quality-of-life in acromegaly: data from the PRIMARYS study.
Caron PJ; Bevan JS; Petersenn S; Houchard A; Sert C; Webb SM;
Pituitary; 2016 Apr; 19(2):149-57. PubMed ID: 26603536
[TBL] [Abstract][Full Text] [Related]
22. Quality of life in acromegaly.
Webb SM
Neuroendocrinology; 2006; 83(3-4):224-9. PubMed ID: 17047387
[TBL] [Abstract][Full Text] [Related]
23. Acromegaly Quality of Life Questionnaire (AcroQoL).
Badia X; Webb SM; Prieto L; Lara N
Health Qual Life Outcomes; 2004 Feb; 2():13. PubMed ID: 14987332
[TBL] [Abstract][Full Text] [Related]
24. More concerns and stronger beliefs about the necessity of medication in patients with acromegaly are associated with negative illness perceptions and impairment in quality of life.
Andela CD; Biermasz NR; Kaptein AA; Pereira AM; Tiemensma J
Growth Horm IGF Res; 2015 Oct; 25(5):219-26. PubMed ID: 26164770
[TBL] [Abstract][Full Text] [Related]
25. Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases?
Anagnostis P; Efstathiadou ZA; Charizopoulou M; Selalmatzidou D; Karathanasi E; Poulasouchidou M; Kita M
Endocrine; 2014 Nov; 47(2):564-71. PubMed ID: 24510628
[TBL] [Abstract][Full Text] [Related]
26. PREDICTORS OF QUALITY OF LIFE IN 165 PATIENTS WITH ACROMEGALY: RESULTS FROM A SINGLE-CENTER STUDY.
Kreitschmann-Andermahr I; Buchfelder M; Kleist B; Kohlmann J; Menzel C; Buslei R; Kołtowska-Häggsträm M; Strasburger C; Siegel S
Endocr Pract; 2017 Jan; 23(1):79-88. PubMed ID: 27749131
[TBL] [Abstract][Full Text] [Related]
27. Quality of Life and its Determinants in Patients With Treated Acromegaly: A Cross-Sectional Nationwide Study in China.
Guo X; Wang K; Yu S; Gao L; Wang Z; Zhu H; Xing B; Zhang S; Dong D
J Clin Endocrinol Metab; 2021 Jan; 106(1):211-225. PubMed ID: 33079177
[TBL] [Abstract][Full Text] [Related]
28. Quality of life after long-term biochemical control of acromegaly.
Kimball A; Dichtel LE; Yuen KCJ; Woodmansee WW; Haines MS; Nachtigall LB; Swearingen B; Jones P; Tritos NA; Sharpless JL; Kaiser UB; Gerweck A; Miller KK
Pituitary; 2022 Jun; 25(3):531-539. PubMed ID: 35476257
[TBL] [Abstract][Full Text] [Related]
29. Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiency who have a history of acromegaly versus other disorders.
Valassi E; Brick DJ; Johnson JC; Biller BM; Klibanski A; Miller KK
Endocr Pract; 2012; 18(2):209-18. PubMed ID: 22440981
[TBL] [Abstract][Full Text] [Related]
30. Mapping of the acromegaly quality of life questionnaire to ED-5D-5L index score among patients with acromegaly.
Wang K; Guo X; Yu S; Gao L; Wang Z; Zhu H; Xing B; Zhang S; Dong D
Eur J Health Econ; 2021 Dec; 22(9):1381-1391. PubMed ID: 33988760
[TBL] [Abstract][Full Text] [Related]
31. Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly.
Hua SC; Yan YH; Chang TC
Eur J Endocrinol; 2006 Dec; 155(6):831-7. PubMed ID: 17132752
[TBL] [Abstract][Full Text] [Related]
32. Clinical Applicability of Patient- and Clinician-Reported Outcome Tools in the Management of Patients With Acromegaly.
Herman R; Goričar K; Janež A; Jensterle M
Endocr Pract; 2022 Jul; 28(7):678-683. PubMed ID: 35421593
[TBL] [Abstract][Full Text] [Related]
33. The effect of treatment on quality of life in patients with acromegaly: a prospective study.
Wolters TLC; Roerink SHPP; Sterenborg RBTM; Wagenmakers MAEM; Husson O; Smit JWA; Hermus ARMM; Netea-Maier RT
Eur J Endocrinol; 2020 Mar; 182(3):319-331. PubMed ID: 31958318
[TBL] [Abstract][Full Text] [Related]
34. Is there any difference in acromegaly and other chronic disease in quality of life and psychiatric morbidity?
Szcześniak DM; Jawiarczyk-Przybyłowska A; Matusiak Ł; Bolanowska A; Maciaszek J; Siemińska M; Rymaszewska J; Bolanowski M
Endokrynol Pol; 2017; 68(5):524-532. PubMed ID: 28879648
[TBL] [Abstract][Full Text] [Related]
35. Persistent negative illness perceptions despite long-term biochemical control of acromegaly: novel application of the drawing test.
Tiemensma J; Pereira AM; Romijn JA; Broadbent E; Biermasz NR; Kaptein AA
Eur J Endocrinol; 2015 May; 172(5):583-93. PubMed ID: 25724922
[TBL] [Abstract][Full Text] [Related]
36. Quality of life in female patients with acromegaly.
Celik O; Kadioglu P
J Endocrinol Invest; 2013 Jun; 36(6):412-6. PubMed ID: 23211278
[TBL] [Abstract][Full Text] [Related]
37. Psychosocial morbidity in acromegaly: a study from India.
Mattoo SK; Bhansali AK; Gupta N; Grover S; Malhotra R
Endocrine; 2008; 34(1-3):17-22. PubMed ID: 18953676
[TBL] [Abstract][Full Text] [Related]
38. Short- and long-term changes of quality of life in patients with acromegaly: results from a prospective study.
Sardella C; Lombardi M; Rossi G; Cosci C; Brogioni S; Scattina I; Webb SM; Gasperi M; Martino E; Bogazzi F
J Endocrinol Invest; 2010 Jan; 33(1):20-5. PubMed ID: 20203538
[TBL] [Abstract][Full Text] [Related]
39. Affected illness perceptions and the association with impaired quality of life in patients with long-term remission of acromegaly.
Tiemensma J; Kaptein AA; Pereira AM; Smit JW; Romijn JA; Biermasz NR
J Clin Endocrinol Metab; 2011 Nov; 96(11):3550-8. PubMed ID: 21917873
[TBL] [Abstract][Full Text] [Related]
40. Acromegaly increases depressive symptoms and reduces quality of life of cohabitants.
Uysal S; Sulu C; Kara Z; Ihtiyaroglu I; Ozkal I; Sahin S; Taze SS; Kirpinar MM; Turan S; Kadioglu P
Pituitary; 2024 Apr; 27(2):169-177. PubMed ID: 38159126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
